Respiratory Tract Diseases  >>  Tracleer (bosentan)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

18 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
NCT00080457: Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Completed
3
240
US
sitaxsentan sodium
Encysive Pharmaceuticals
Pulmonary Hypertension
 
01/05
NCT00091715 / 2004-000478-30: Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II

Completed
3
185
US, Canada, Europe, RoW
bosentan, Tracleer, placebo
Actelion
Pulmonary Hypertension
11/06
02/11
FUTURE-1, NCT00319267 / 2004-005157-63: Bosentan in Children With Pulmonary Arterial Hypertension

Completed
3
36
US, Europe
Bosentan, ACT-050088, Ro 47-0203
Actelion
Pulmonary Arterial Hypertension
12/06
02/07
NCT00313222 / 2005-001965-33: Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension

Completed
3
157
US, Canada, Europe, RoW
bosentan
Actelion
Chronic Thromboembolic Pulmonary Hypertension
02/07
03/07
ASSET-3, NCT00360087 / 2006-000374-75: A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

Terminated
3
236
US, Europe
Bosentan
Actelion, National Heart, Lung, and Blood Institute (NHLBI)
Pulmonary Hypertension, Sickle Cell Anemia
08/07
12/07
ASSET-2, NCT00313196: Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)

Terminated
3
12
US, Europe
bosentan
Actelion
Pulmonary Hypertension
08/07
08/07
VISION, NCT00302211 / 2005-006192-13: The "" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Terminated
3
67
US
Inhaled Iloprost (5 μg), Inhaled Placebo, Sildenafil, Bosentan
Actelion
Pulmonary Hypertension
12/07
07/08
BENEFIT OL, NCT00319111 / 2005-002900-40: Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Completed
3
151
US, Canada, Europe, RoW
bosentan
Actelion
Pulmonary Hypertension
02/09
04/09
BUILD 3, NCT00391443 / 2006-001183-24: Bosentan Use in Interstitial Lung Disease

Completed
3
616
Japan, US, Canada, Europe, RoW
Bosentan, Ro 47-0203, ACT-050088, Placebo
Actelion
Idiopathic Pulmonary Fibrosis
02/10
07/10
BUILD OL, NCT00631475 / 2007-001741-18: Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Completed
3
128
Japan, US, Canada, Europe, RoW
Bosentan, Tracleer
Actelion
Idiopathic Pulmonary Fibrosis
04/10
05/10
FUTURE 2, NCT00319020 / 2005-001967-70: Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

Completed
3
33
US, Europe
Bosentan, Ro 47-0203, Tracleer
Actelion
Pulmonary Arterial Hypertension
10/11
10/11
FUTURE 4, NCT01389856 / 2011-000203-41: Persistent Pulmonary Hypertension of the Newborn

Terminated
3
23
US, Europe, RoW
Bosentan, Tracleer, Matching placebo
Actelion
Persistent Pulmonary Hypertension of the Newborn
12/13
01/14
BADDHY, NCT00820352 / 2008-005514-40: Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension

Completed
3
20
Europe
bosentan, Ro 47.0203, placebo
University Teaching Hospital Hall in Tirol
Heart Failure, Diastolic, Hypertension, Pulmonary
06/14
06/14
NCT00070590: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Completed
2/3
132
US, Europe, RoW
Bosentan
Actelion
Pulmonary Fibrosis, Scleroderma, Systemic
09/05
09/05
BUILD 1, NCT00071461: Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

Completed
2/3
158
US, Canada, Europe, RoW
bosentan, Tracleer, Placebo
Actelion
Idiopathic Pulmonary Fibrosis
09/05
05/10
BUILD 2 OL, NCT00319033 / 2004-000631-28: Open-label Study With Bosentan in Interstitial Lung Disease

Completed
2/3
132
US, Canada, Europe, RoW
bosentan
Actelion
Interstitial Lung Disease, Scleroderma
02/06
02/06
BOSAPAH, NCT00581607: Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension

Completed
2/3
43
US
Bosentan, Tracleer, Placebo, tracleer
University of Cincinnati, Actelion
Sarcoidosis, Pulmonary Arterial Hypertension
10/12
12/12
ERAATH, NCT01352065: Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration

Completed
2/3
30
RoW
Bosentan, Ambrisentan, Placebo
Center for Health, Exercise and Sport Sciences, Serbia
Pulmonary Hypertension
12/12
05/13

Download Options